{"title":"Comparison of efficacy and safety of endoscopic and radiological interventions for gastric varices: A systematic review and network meta-analysis.","authors":"Suprabhat Giri, Vaneet Jearth, Vishal Seth, Harish Darak, Sridhar Sundaram","doi":"10.5114/ceh.2023.126077","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>There is a paradigm shift in the management of gastric varices with the availability of endoscopic ultrasound and radiologic interventions. The optimal choice of intervention remains a dilemma for most treating physicians.</p><p><strong>Material and methods: </strong>We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and ScienceDirect for studies comparing endoscopic glue injection, endoscopic thrombin injection (THB), variceal band ligation, EUS-guided coiling, EUS-guided glue injection, EUS-guided coiling with glue (EUS-C+G), balloon occluded retrograde transvenous obliteration (BRTO), and transjugular intrahepatic portosystemic shunt (TIPS) for gastric varices in adults. The data on four outcomes - obliteration of varices, rebleeding, adverse effects, and mortality - were pooled using a random-effects model. Treatment estimates were calculated as odds ratios (ORs) along with their 95% confidence interval (CI). The relative ranking of interventions for various outcomes was calculated as their surface under the cumulative ranking curve (SUCRA).</p><p><strong>Results: </strong>We identified 34 studies (10 randomized controlled trials, 24 non-randomized trials) with 2783 patients. Based on SUCRA plots, BRTO (SUCRA 95.1) had the highest rate of variceal obliteration followed by EUS-C+G (SUCRA 80.9). The risk of rebleeding was lowest with BRTO (SUCRA 85.1) followed by EUS-C+G (SUCRA 78.8). Moderate-severe adverse effects were least likely with THB (SUCRA 92.5) and highest with TIPS (SUCRA 3.7). In terms of mortality, EUS-C+G (73.5) had the lowest probability of overall mortality followed by TIPS (69.1).</p><p><strong>Conclusions: </strong>In this network meta-analysis, we found BRTO and EUS-guided therapies to be superior to endoscopic glue injection. However, the level of evidence remains low.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"9 1","pages":"57-70"},"PeriodicalIF":1.5000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/35/CEH-9-50402.PMC10090989.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2023.126077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim of the study: There is a paradigm shift in the management of gastric varices with the availability of endoscopic ultrasound and radiologic interventions. The optimal choice of intervention remains a dilemma for most treating physicians.
Material and methods: We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and ScienceDirect for studies comparing endoscopic glue injection, endoscopic thrombin injection (THB), variceal band ligation, EUS-guided coiling, EUS-guided glue injection, EUS-guided coiling with glue (EUS-C+G), balloon occluded retrograde transvenous obliteration (BRTO), and transjugular intrahepatic portosystemic shunt (TIPS) for gastric varices in adults. The data on four outcomes - obliteration of varices, rebleeding, adverse effects, and mortality - were pooled using a random-effects model. Treatment estimates were calculated as odds ratios (ORs) along with their 95% confidence interval (CI). The relative ranking of interventions for various outcomes was calculated as their surface under the cumulative ranking curve (SUCRA).
Results: We identified 34 studies (10 randomized controlled trials, 24 non-randomized trials) with 2783 patients. Based on SUCRA plots, BRTO (SUCRA 95.1) had the highest rate of variceal obliteration followed by EUS-C+G (SUCRA 80.9). The risk of rebleeding was lowest with BRTO (SUCRA 85.1) followed by EUS-C+G (SUCRA 78.8). Moderate-severe adverse effects were least likely with THB (SUCRA 92.5) and highest with TIPS (SUCRA 3.7). In terms of mortality, EUS-C+G (73.5) had the lowest probability of overall mortality followed by TIPS (69.1).
Conclusions: In this network meta-analysis, we found BRTO and EUS-guided therapies to be superior to endoscopic glue injection. However, the level of evidence remains low.
本研究的目的:随着超声内镜和放射干预的可用性,胃静脉曲张的治疗模式发生了转变。干预的最佳选择仍然是大多数治疗医生的两难选择。材料和方法:我们检索MEDLINE、Cochrane中央对照试验注册库(Cochrane Central Register of Controlled Trials)和ScienceDirect,以比较内镜下注射胶水、内镜下注射凝血酶(THB)、静脉曲张束结扎、eus引导下的卷取术、eus引导下的注射胶水、eus引导下的带胶卷取术(EUS-C+G)、球囊闭塞逆行经静脉闭塞术(BRTO)和经颈静脉肝内门静脉分流术(TIPS)治疗成人胃静脉曲张的研究。四项结果的数据——静脉曲张闭塞、再出血、不良反应和死亡率——使用随机效应模型进行汇总。治疗估计以比值比(ORs)及其95%置信区间(CI)计算。在累积排序曲线(SUCRA)下计算干预措施对不同结果的相对排序。结果:我们纳入34项研究(10项随机对照试验,24项非随机试验),共2783例患者。根据SUCRA图,BRTO (SUCRA 95.1)的静脉曲张闭塞率最高,其次是EUS-C+G (SUCRA 80.9)。BRTO组再出血风险最低(SUCRA为85.1),其次是EUS-C+G组(SUCRA为78.8)。中重度不良反应在THB组发生的可能性最小(SUCRA为92.5),在TIPS组发生的可能性最大(SUCRA为3.7)。在死亡率方面,EUS-C+G(73.5)的总死亡率最低,其次是TIPS(69.1)。结论:在这个网络荟萃分析中,我们发现BRTO和eus引导的治疗优于内镜注射胶。然而,证据水平仍然很低。
期刊介绍:
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.